2020
DOI: 10.1186/s12936-020-03209-5
|View full text |Cite
|
Sign up to set email alerts
|

Development of a dissolution method for lumefantrine and artemether in immediate release fixed dose artemether/lumefantrine tablets

Abstract: Background: Dissolution of artemether (ART) and lumefantrine (LUM) active pharmaceutical ingredients (APIs) in fixed dose combination (FDC) ART/LUM tablets is one of the critical quality attributes. Thus, the verification of the release profile of ART and LUM from FDC ART/LUM tablets using a robust and discriminatory dissolution method is crucial. Therefore, the aim of this study was to develop and validate an appropriate dissolution method for quality control of FDC ART/LUM tablets. Methods: The dissolution m… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

0
4
0

Year Published

2021
2021
2024
2024

Publication Types

Select...
6
1

Relationship

0
7

Authors

Journals

citations
Cited by 8 publications
(4 citation statements)
references
References 35 publications
0
4
0
Order By: Relevance
“…Regarding the dissolution test, the water medium was tested but LMF did not dissolve, even after 3 hours, because it is insoluble in water and AMT was partly dissolved as previous reports indicated [ 44 ]. Then, 0.1 N chloride acid (HCl) containing 1% benzalkonium chloride was used to perform the AMT/LMF tablets dissolution test just employing 6 units and not 12 (in the first stage of dissolution test) as the proposed USP monograph recommends [ 34 ].…”
Section: Resultsmentioning
confidence: 99%
See 1 more Smart Citation
“…Regarding the dissolution test, the water medium was tested but LMF did not dissolve, even after 3 hours, because it is insoluble in water and AMT was partly dissolved as previous reports indicated [ 44 ]. Then, 0.1 N chloride acid (HCl) containing 1% benzalkonium chloride was used to perform the AMT/LMF tablets dissolution test just employing 6 units and not 12 (in the first stage of dissolution test) as the proposed USP monograph recommends [ 34 ].…”
Section: Resultsmentioning
confidence: 99%
“…Dissolution tests were performed following USP recommendations, see Table 1 [ 43 ]. In the case of AMT/LMF tablets, as an official monography is not available, different mediums were studied based on literature [ 34 , 44 ]. For all medicines, paddle apparatus was used [ 33 , 34 , 36 , 45 ].…”
Section: Methodsmentioning
confidence: 99%
“…The pH dissolution method was used to evaluate drug release from pellets. 26 The GPs quickly disintegrated completely in the artificial gastric juice, resulting in a high release rate (pH 1.2, cumulative release over 98% in 5 min). The release of BBR from EPs was determined by using a ChP (2020 edition) dissolution apparatus II (basket method) at a rotation speed of 100 r/min in 750 mL of dissolution medium at 37 ± 0.5 °C under sink conditions.…”
Section: Methodsmentioning
confidence: 99%
“…The general procedure to develop a dissolution method includes (1) understanding the properties of drug substance and drug product, (2) evaluating sink conditions, (3) optimizing the dissolution conditions, and (4) evaluating the dissolution profiles and finalizing the method conditions [14][15][16][17][18][19][20][21]. One-factor-at-a-time (OFAT) approach is commonly used for process and method optimization [22,23]. Although this approach is straightforward and easy to implement, it may take longer to identify the optimal conditions that yield an appropriate dissolution profile with sufficient discrimination power.…”
Section: Introductionmentioning
confidence: 99%